An investigation of 2'-deoxycoformycin in the treatment of cutaneous T- cell lymphoma

The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy

1981 • 199 citations

In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients.

1979 • 168 citations

Prospective Staging Evaluation of Patients with Cutaneous T-Cell Lymphomas

1980 • 154 citations

REMISSION INDUCTION WITH ADENOSINE-DEAMINASE INHIBITOR 2'-DEOXYCOFORMYCIN IN THY-LYMPHOBLASTIC LEUKÆMIA

1980 • 113 citations

Clinical pharmacology of deoxycoformycin

1981 • 107 citations

The clinical pharmacology of the adenosine deaminase inhibitor 2?-deoxycoformycin

1980 • 88 citations

Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia.

1981 • 88 citations

Inhibition of adenosine deaminase activity results in cytotoxicity to T lymphoblasts in vivo

1980 • 75 citations

Combination chemotherapy for mycosis fungoides: a Southwest Oncology Group study.

1979 • 50 citations